Results 271 to 280 of about 272,686 (351)

Exploring new horizons: angiotensin II, angiotensin II type 1 receptor, and renal outer medullary potassium channel interaction in distal convoluted tubule. [PDF]

Kidney Res Clin Pract
Zhao K, Han T, Jia L, Wen L, Gao R, Li X.   +5 more
europepmc   +1 more source

SIRT1, a Longevity Gene, Downregulates Angiotensin II Type 1 Receptor Expression in Vascular Smooth Muscle Cells

Arteriosclerosis, Thrombosis and Vascular Biology, 2008
Ryohei Miyazaki, T. Ichiki, T. Hashimoto, Keita Inanaga, I. Imayama, J. Sadoshima, K. Sunagawa   +6 more
semanticscholar   +1 more source

Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: Long‐Term Follow‐Up of Deformations and Hemodynamics

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background A detailed evaluation of hemodynamics, supportive morphology, and deformation may help uncover the pathophysiology of hypertrophic obstructive cardiomyopathy (HOCM) and the changes wrought by alcohol septal ablation (ASA). Purpose To investigate the global cardiac volume, myocardial deformation, and hemodynamic characteristics ...
Kenichiro Suwa, Kazuto Ohno, Terumori Satoh, Ryota Sato, Keisuke Iguchi, Yuichiro Maekawa   +5 more
wiley   +1 more source

A strategy for selective screening of dual-target bioactive compounds against hypertrophic scar through inhibiting angiotensin II type 1 receptor while stimulating type 2 receptor from Chinese herbs. [PDF]

Chin Med
Qu L, Jiao M, Zhang Z, Ou Y, Zhao X, Zhang Y, Zhao X.   +6 more
europepmc   +1 more source

Combined Blockade of the Renin-Angiotensin System With Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Antagonists

Circulation, 2004
M. Azizi, J. Ménard
semanticscholar   +1 more source

MiR‐145‐5p Attenuates Doxorubicin‐Induced Heart Injury Through Targeting Cardiomyocyte Pyroptosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Doxorubicin (DOX), a potent anthracycline chemotherapeutic, exhibits dose‐dependent cardiotoxicity that limits its clinical utility. Although miR‐145‐5p demonstrates cardioprotective properties in cardiovascular diseases, its role in DOX‐induced cardiomyopathy remains undefined.
Xing‐Tao Chen, Yong‐Hong Yu, Yan‐Hua Du, Lin Xu, Xiang‐Ping Meng   +4 more
wiley   +1 more source

Development of angiotensin II type 1 receptor antibodies in patients with temporary mechanical circulatory support. [PDF]

JHLT Open
Gamero MT, Liotta M, Brailovsky Y, Gibson G, Alvarez R, Uber P, Huang Y, Rajapreyar I.   +7 more
europepmc   +1 more source

Angiotensin II Type-1 Receptor Blocker Valsartan Enhances Insulin Sensitivity in Skeletal Muscles of Diabetic Mice

HYPERTENSION, 2004
T. Shiuchi, M. Iwai, Huan Li, Lan Wu, Li-Juan Min, Jian-Mei Li, Midori Okumura, T. Cui, M. Horiuchi   +8 more
semanticscholar   +1 more source

Sacubitril/Valsartan Ameliorates Inflammation and Oxidative Stress in Hypertensive Heart Disease by Upregulating CAMKK2 Protein and Modulating the AMPK/AKT/GSK‐3β Axis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Sacubitril/valsartan (Sac/Val) has emerged as an effective compound with myocardium‐protective functions in experimental and clinical trials for heart failure. This study investigated the function of Sac/Val in hypertensive heart disease (HHD) and explored the underlying mechanism.
Yan‐Jun Yang, Jiu‐Sheng Li
wiley   +1 more source